首页 › 基金 › Blue Owl Capital Holdings LP › CGEM

Blue Owl Capital Holdings LP 对 CGEM 的持仓历史

CULLINAN THERAPEUTICS INC · 医疗保健

Blue Owl Capital Holdings LP 在 Q3 2026 的 13F 申报中披露持有 CGEM(CULLINAN THERAPEUTICS INC)1,399,899 股,市值约 US$21.5M,约占其申报组合的 4.04%,在其申报持仓中市值排名第 8 位。 Blue Owl Capital Holdings LP 最近 12 个申报季度中有 12 个季度披露了 CGEM 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)1.40M 股
申报持仓市值$21.49M
组合权重4.04%
首次申报Q4 2023
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Blue Owl Capital Holdings LP 对 CGEM 的持仓演变

Blue Owl Capital Holdings LP 于 Q4 2023 首次披露 CGEM 持仓:3,419,842 股(约 US$34.8M)。 该持仓在 Q1 2024 达到峰值 2,924,842 股,市值约 US$49.8M。 在 12 次申报中,Blue Owl Capital Holdings LP 3 次增持、8 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,399,899 股、市值约 US$21.5M,环比减持 -139,865 股。。 持仓曾出现大幅变动:Q2 2024 减持约 30% (随后一个季度股价下跌 4%)。

逐季持仓明细

季度股数金额变化
Q4 2023 3.42M $34.85M 新进
Q1 2024 2.92M $49.84M 减持
Q2 2024 2.05M $35.74M 减持
Q3 2024 2.01M $33.66M 减持
Q4 2024 2.37M $28.88M 增持
Q1 2025 2.44M $18.44M 增持
Q2 2025 2.39M $17.97M 减持
Q3 2025 2.51M $14.89M 增持
Q4 2025 2.35M $24.33M 减持
Q1 2026 1.91M $27.14M 减持
Q2 2026 1.54M $28.04M 减持
Q3 2026 1.40M $21.49M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CGEM 与 13F 数据

CGEM(CULLINAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 CGEM,申报仓位最大的包括:MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CGEM 的基金

查看 CGEM 的全部基金持有人 →

常见问题

How long has Blue Owl Capital Holdings LP held CGEM?

Blue Owl Capital Holdings LP has disclosed CGEM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Blue Owl Capital Holdings LP's current position in CGEM?

As of Q3 2026, Blue Owl Capital Holdings LP holds 1.40M shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $21.49M, representing 4.04% of its reported portfolio and ranking #8.

Has Blue Owl Capital Holdings LP been buying or selling CGEM?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP reduced its position in CGEM. The position peaked in Q1 2024 at 2.92M shares.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.